Abstract
A multilaboratory study designed to determine the in vitro susceptibility criteria and quality control parameters for ofloxacin against Neisseria gonorrhoeae was conducted according to the guidelines of the National Committee for Clinical Laboratory Standards. Proposed susceptibility breakpoints are MICs of less than or equal to 0.25 microgram/ml for the agar dilution test and greater than or equal to 31 mm for the disk diffusion test. A category for resistance could not be defined. Proposed acceptable quality control MICs for N. gonorrhoeae ATCC 49226 and Staphylococcus aureus ATCC 29213 range from 0.004 to 0.03 microgram/ml and 0.25 to 1.0 microgram/ml, respectively. With 5-micrograms ofloxacin disks, acceptable inhibitory zone diameters for S. aureus ATCC 25923 and the N. gonorrhoeae control strains range from 22 to 27 mm and 43 to 51 mm, respectively.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Batteiger B. E., Jones R. B., White A. Efficacy and safety of ofloxacin in the treatment of nongonococcal sexually transmitted disease. Am J Med. 1989 Dec 29;87(6C):75S–77S. [PubMed] [Google Scholar]
- Black J. R., Long J. M., Zwickl B. E., Ray B. S., Verdon M. S., Wetherby S., Hook E. W., 3rd, Handsfield H. H. Multicenter randomized study of single-dose ofloxacin versus amoxicillin-probenecid for treatment of uncomplicated gonococcal infection. Antimicrob Agents Chemother. 1989 Feb;33(2):167–170. doi: 10.1128/aac.33.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Covino J. M., Cummings M., Smith B., Benes S., Draft K., McCormack W. M. Comparison of ofloxacin and ceftriaxone in the treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing strains. Antimicrob Agents Chemother. 1990 Jan;34(1):148–149. doi: 10.1128/aac.34.1.148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gavan T. L., Jones R. N., Barry A. L., Fuchs P. C., Gerlach E. H., Matsen J. M., Reller L. B., Thornsberry C., Thrupp L. D. Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study. J Clin Microbiol. 1981 Jul;14(1):67–72. doi: 10.1128/jcm.14.1.67-72.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Judson F. N., Beals B. S., Tack K. J. Clinical experience with ofloxacin in sexually transmitted disease. Infection. 1986;14 (Suppl 4):S309–S310. doi: 10.1007/BF01661303. [DOI] [PubMed] [Google Scholar]
- Lutz F. B., Jr Single-dose efficacy of ofloxacin in uncomplicated gonorrhea. Am J Med. 1989 Dec 29;87(6C):69S–74S. [PubMed] [Google Scholar]
- Melby K., Faegri A. The in vitro activity of norfloxacin, ofloxacin and ciprofloxacin and other antibiotics in current use against Neisseria gonorrhoeae. APMIS. 1989 Apr;97(4):347–350. [PubMed] [Google Scholar]